دورية أكاديمية

Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery

التفاصيل البيبلوغرافية
العنوان: Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
المؤلفون: Ray, Abhik Kumar, Sen Gupta, Parth Sarthi, Panda, Saroj Kumar, Biswal, Satyaranjan, Bhattacharya, Uddipan, Rana, Malay Kumar
المصدر: Computers in Biology and Medicine ; volume 142, page 105183 ; ISSN 0010-4825
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Health Informatics, Computer Science Applications
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.compbiomed.2021.105183
الإتاحة: https://doi.org/10.1016/j.compbiomed.2021.105183Test
https://api.elsevier.com/content/article/PII:S001048252100977X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S001048252100977X?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test
رقم الانضمام: edsbas.CD5E510F
قاعدة البيانات: BASE